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INTRODUCTION
Staphylococcus aureus, which normally colonizes the anteri-
or nares, can induce a variety of infections, ranging from super-
ficial lesions to toxic shock syndrome and severe systemic in-
fections. Since the first report in 1961 in U.K., the emergence
and dissemination of methicillin-resistant S. aureus (MRSA)
has become a subject of great global concern (1). In Korea,
MRSA is responsible for more than 60% of S. aureus infec-
tions in hospitals, and constitutes a continuing threat to pub-
lic health (2-4). Clinical MRSA isolates from Korean hospi-
tals generally are identified as the two predominant clones,
ST5-MRSA-II or ST239-MRSA-III (5-7). However, the ma-
jority of studies have focused on any clinical MRSA strains,
without regard to their disease characteristics. That is to say,
there are few studies reporting the molecular characteristics
of MRSA and methicillin-susceptible S. aureus (MSSA) caus-
ing bacteremia in Korea (8). 
Virulence determinants may have been crucial to the evolu-
tion of contemporary epidemic strains of S. aureus (9, 10). So
far, a variety of virulence genes have been identified in S. aureus.
They include staphylococcal enterotoxins (SEs), staphylococ-
cal exofoliative toxins (ETs), toxic shock syndrome toxin 1
(TSST-1), and the Panton-Valentine leukocidin (PVL). Among
these, the SEs are emetic toxins, and have been implicated
in food poisoning in humans. TSST-1, which is also a mem-
ber of the superantigenic toxin family, has been associated
with several acute or chronic human diseases, including toxic
shock syndrome and, possibly, sudden infant death syndrome
and Kawasaki syndrome (11). PVL is known to be associat-
ed with tissue necrosis, and is frequently found in commu-
nity-associated MRSA (CA-MRSA) (12). It has been demon-
strated that the horizontal transfer of these virulence genes
is one of the causes of the emergence of new virulent MRSA
strains (9). Recently, the prevalence of enterotoxin genes in
S. aureus isolates associated with staphylococcal food poison-
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Comparison of Genotypes and Enterotoxin Genes Between 
Staphylococcus aureus Isolates from Blood and Nasal Colonizers 
in a Korean Hospital
In this study, we investigated the genetic background of 70 Staphylococcus aureus
isolates (36 methicillin-resistant S. aureus [MRSA] and 34 methicillin-susceptible S.
aureus [MSSA]) obtained from blood at a Korean tertiary-care hospital, using spa
typing, multilocus sequence typing, and SCCmec typing. In addition, the prevalence
of enterotoxin (sea, seb, sec, sed, see, seg, seh, sei, and sek), tst, and pvl genes
among the samples was assessed via polymerase chain reaction, and the results
were compared with those of 95 isolates of S. aureus obtained from nasal swabs.
All MRSA isolates from blood, except one, belonged to three major clones: sequence
type (ST)5-MRSA-II, ST72-MRSA-II (or IVA), and ST239-MRSA-III, among which
ST5-MRSA-II was the predominant clone. The prevalence of enterotoxin genes in
the S. aureus isolates obtained from blood differed significantly from those from the
nasal swabs for the sea, seb, sec, and seh gene. In particular, the seb and sec genes
were detected exclusively in the MRSA isolates of ST5 or spa-CC002, thereby sug-
gesting the co-adaptation of virulence genes with the genetic background and their
contribution to biological fitness. 
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Accepted : 26 September 2008ing in Korea was investigated (13). 
Detailed knowledge of genotype and virulence gene con-
tent may be a prerequisite for understanding of the genetic
basis of prevailing clones of bacterial pathogens (9). Genetic
backgrounds and the prevalence of enterotoxins may be dif-
ferent between disease-causing and colonizing strains. Thus,
we have attempted to characterize the molecular character-
istics of S. aureus isolated from blood in a Korean hospital,
and have compared them with isolates of S. aureus from nasal
swab specimens. In addition, we have evaluated the prevalence
of virulence genes among S. aureus isolates obtained from blood
and nasal specimens. 
MATERIALS AND METHODS
Bacterial isolates 
Seventy isolates of S. aureus obtained from blood were con-
secutively collected at a tertiary-care hospital (Samsung Medi-
cal Center) in Seoul, Korea over a five-month period (January
to May) in 2006. In addition, 95 S. aureus isolates from nasal
swabs of children attending an outpatient clinic in a tertiary-
care hospital (14) were also included in this study. These iso-
lates were collected from the same hospital over a similar pe-
riod (December 2005 to February 2006) with the S. aureus
isolates from blood. All of the isolates were identified using
a Staphaurex Plus Kit (Murex Diagnostics Ltd., Dartford,
U.K.), which were confirmed by molecular typing methods
such as multilocus sequence typing (MLST) and spa typing. 
Antimicrobial susceptibility testing 
In vitro antimicrobial susceptibility testing was performed
by a broth microdilution method according to the Clinical
and Laboratory Standards Institute (CLSI) (15). The mini-
mum inhibitory concentrations (MICs) of 11 antimicrobial
agents were determined: oxacillin, penicillin, gentamicin,
ciprofloxacin, clindamycin, erythromycin, rifampin, vanco-
mycin, teicoplanin, tetracycline, and trimethoprim-sulfame-
thoxazole. Susceptibility interpretive criteria used were those
established in the CLSI standard M100-S16 (15). S. aureus
ATCC 29213, Enterococcus faecalis ATCC 29212, and Escherichia
coli ATCC 25922 were employed as control strains. 
Genotyping 
In order to determine the genotype of S. aureus isolates, spa
typing was initially conducted as previously described (16-
18). With the BURP algorithm (Ridom GmbH), spa types
were clustered into spa clonal complex (spa-CC) (16, 19). MLST
was performed for 28 S. aureus isolates from blood, which were
representative of each spa type, in accordance with a previous-
ly described method (20) with the exception of a primer pair
amplifying the yqiL gene (forward, 5′ -TAT TAG CAG CAT
ACA GGA C-3′ ; reverse, 5′ -CAC CTT TAC GTT GAG
GAA TC-3′ ). The staphylococcal chromosomal casette mec
(SCCmec) types of all MRSA isolates were determined by the
method of multiplex polymerase chain reaction (PCR) (21). 
Virulence gene detection 
The detection of toxin genes (sea, seb, sec, sed, see, seg, seh, sei,
sek, and tst) was achieved via the method previously described
by Jarraud et al. (10). PCR was performed independently for
each toxin gene. The Panton-Valentine leukocidin (pvl) gene
was detected using the primers previously described by Lina
et al. (22). 
Statistical analysis
Fisher’s exact t-test and chi-square test were utilized to de-
termine the significance of differences in resistance, where
appropriate. 




MRSA, methicillin-resistant S. aureus; MSSA, methicillin-susceptible S. aureus. 
MIC90 (mg/L)
MSSA (n=34)
R (%) MIC90 (mg/L)
Total (n=70)
R (%) MIC90 (mg/L)
Oxacillin 36 (100) >64 - 0.5 36 (51.4) >64
Penicillin 36 (100) >32 30 (88.2) 32 66 (94.3) >32
Gentamicin 30 (83.3) >64 5 (14.7) >64 35 (50.0) >64
Ciprofloxacin 30 (83.3) >32 3 (8.8) 0.5 33 (47.2) 32
Clindamycin 30 (83.3) >32 1 (3.0) 0.12 31 (44.3) >32
Erythromycin 32 (88.9) >64 6 (17.7) 64 38 (54.3) >64
Rifampin 2 (5.6) ≤0.016 - ≤0.016 2 (2.9) ≤0.016
Tetracycline 26 (72.2) >64 3 (8.8) 0.5 29 (41.4) >64
Trimethoprim-sulfamethoxazole 3 (8.3) 0.25/4.75 2 (5.9) 0.06/1.18 5 (7.2) 0.12/2.37
Vancomycin - 1 - 1 - 1
Teicoplanin - 8 - 0.5 - 8
Table 1. Antimicrobial resistance of S. aureus isolates from bloodRESULTS
Antimicrobial resistances
Among the 70 S. aureus isolates from blood, 36 isolates
(51.4%) were found to be methicillin-resistant and 34 iso-
lates (48.6%) were methicillin-susceptible. More than 80%
of MRSA isolates were resistant to gentamicin, ciprofloxacin,
clindamycin, and erythromycin. In addition, tetracycline resis-
tance rate among MRSA isolates was 72.2%. However, less
than 20% of MSSA isolates proved resistant to those antimi-
crobials except penicillin (Table 1). No S. aureus isolates were
found to be resistant to vancomycin or teicoplanin. 
Among 95 S. aureus isolates from nasal specimens, 18 were
methicillin-resistant (18.9%). Among them, 44 (46.3%), 18
(18.9%), 11 (11.6%), 10 (10.5%), and 3 isolates (3.2%) were
resistant to erythromycin, gentamicin, tetracycline, clinda-
mycin, and ciprofloxacin, respectively (14). 
Genotypes of S. aureus isolates from blood
Thirty-six MRSA isolates from blood evidenced 10 spa types
from three spa-CCs (Table 2). Among the 36 MRSA isolates,
24 isolates (66.7%) belonged to spa-CC002, which share the
same DMGMK motif. As five representative isolates were
identified as sequence type (ST)5 in MLST analysis and all
but one were identified as SCCmec type II, the MRSA isolates
of spa-CC002, may represent ST5-MRSA-II. Five MRSA iso-
lates belonged to spa-CC037, all of which harbor the WG-
KAOMQ motif. All five isolates were identified as SCCmec
type III, and two representative isolates evidenced ST239
and a single locus variant (SLV) of ST239. Thus, this group
may represent ST239-MRSA-III and its allies. Seven MRSA
isolates were associated with spa-CC084, which evidence the
ST72. Each of the two MRSA isolates of spa type UJGGMD-
MGGM were identified as SCCmec types II or IVA, and two
isolates of spa type UJGFGMDMGGM were identified as









spa-CC002 (24) TJMBMDMGMK (15) t002 (26-23-17-34-17-20-17-12-17-16) ST5 (1-4-1-4-12-1-10)  II (14) NT (1)
TMBBMDMMMK (5)  t2460 (26-17-34-34-17-20-17-17-17-16) ST5 (1-4-1-4-12-1-10)  II (5)
TJMBBMDMGMK (2) t601 (26-23-17-34-34-17-20-17-12-17-16) ST5 (1-4-1-4-12-1-10)  II (2)
TJMGMK (1) t062 (26-23-17-12-17-16) ST5 (1-4-1-4-12-1-10)  II (1)
TKBBMDMGMK (1) t2458 (26-16-34-34-17-20-17-12-17-16) ST5 (1-4-1-4-12-1-10)  II (1)
spa-CC037 (5) WGKAOMQ (4) t037 (15-12-16-02-25-17-24) SLV of ST239 (2-3-1-new
� -4-4-3) III (4)
WGKAKAOMQ (1) t021 (15-12-16-02-16-02-25-17-24) ST239 (2-3-1-1-4-4-3)  III (1)
spa-CC084 (7) UJGGMDMGGM (4) t324 (07-23-12-12-17-20-17-12-12-17) ST72 (1-4-1-8-4-4-3)  II (2), IVA (2)
UJGFGMDMGGM (2) t148 (07-23-12-21-12-17-20-17-12-12-17) ST72 (1-4-1-8-4-4-3)  IVA (2)
UJGFMB (1) t189 (07-23-12-21-17-34) ST188 (3-1-1-8-1-1-1)  IIIA (1)
MSSA (34 isolates)
spa-CC002 (1) TJMBMDMGMK (1) t002 (26-23-17-34-17-20-17-12-17-16) ST5 (1-4-1-4-12-1-10)
spa-CC037 (9) WFKAOMQ (2) t338 (15-21-16-02-25-17-24) ST30 (2-2-2-2-6-3-2)
WGKAOMQ (3) t037 (15-12-16-02-25-17-24) ST239 (2-3-1-1-4-4-3) 
WGKAKAOMQ (1) t021 (15-12-16-02-16-02-25-17-24) ST30 (2-2-2-2-6-3-2)
WGKAKAOMQQQ (1) t018 (15-12-16-02-16-02-25-17-24-24-24) ST30 (2-2-2-2-6-3-2)
XKAKAOMQ (1) t019 (08-16-02-16-02-25-17-24) SLV of ST30 (2-2-new
c-2-6-3-2) 
XKAKAOMQQ (1) t122 (08-16-02-16-02-25-17-24-24) ST30 (2-2-2-2-6-3-2)
spa-CC084 (12) UJGFMB (4) t189 (07-23-12-21-17-34) ST188 (3-1-1-8-1-1-1)
UDGFMB (1) NEW




�(07-17-21-34-34-22-34) ST513 (4-9-1-8-1-78-8) 
UJGBBGGJAGJ (2) t084 (07-23-12-34-34-12-12-23-02-12-23) ST15 (13-13-1-1-12-11-13)
UJGGBBBPB (1) t1234 (07-23-12-12-34-34-34-33-34) ST97 (3-1-1-1-1-5-3)
UJFKBPE (2) t127 (07-23-21-16-34-33-13) ST1 (1-1-1-1-1-1-1)
spa-CC008 (8) YHGFMBQBLO (5) t008 (11-19-12-21-17-34-24-34-22-25) ST8 (3-3-1-1-4-4-3)
YGFCBQBLO (1) NEW
�(11-12-21-05-34-24-34-22-25) ST8 (3-3-1-1-4-4-3) 
ZAGFMBLO (2) t377 (04-02-12-21-17-34-22-25) ST630 (12-2-1-1-4-4-3)
Singleton (4) ZDMDMQOB (4) t1151 (04-20-17-20-17-24-25-34) SLV of ST59 (new
� -23-15-2-19-20-15)
Table 2. Genotypes of 36 MRSA and 34 MSSA isolates from blood
*MLST was performed on representative isolates for each spa type (20); 
� NT, non-typeable (21); 
� Alleles and ST that were not found in the MLST web-
site (http//saureus.mlst.net) were designated ‘new’. 
MRSA, methicillin-resistant S. aureus; MSSA, methicillin-susceptible S. aureus; MLST, multilocus sequence typing. SCCmec type IVA. A remaining isolate of spa-CC084 showed
spa type UJGFMB represents ST188-MRSA-IIIA. 
The 34 MSSA isolates were differentiated into 18 spa types,
which could be further classified into four spa-CCs and a sin-
gleton (Table 2). Nine MSSA isolates belonged to spa-CC037
(26.5%), which harbored six spa types. We performed MLST
for each MSSA isolate of the six spa types of spa-CC037. Among
them, five showed ST30 or its SLV, and one showed ST239.
Twelve MSSA isolates belonged to spa-CC084, and six MSSA
isolates belonged to spa-CC008. Each two MSSA isolates of
spa-CC084 represented ST188 and ST513, which shared the
same alleles in three loci: glpF, gmk, and pta. MSSA isolates
of the spa-CC008 were consistent with ST8 and its double
locus variant, ST630. Only one MSSA isolate showed a spa
type in spa-CC002, TJMBMDMGMK, which is the most
prevalent clone among MRSA isolates. 
Prevalence of enterotoxin genes and pvl gene
Among the 70 S. aureus isolates obtained from blood, 50
of the isolates (71.4%) harbored at least one enterotoxin gene
(Table 3, 4). The most prevalent enterotoxin gene was seg
(58.6%), followed by the sei (55.7%), tst (44.3%), and sec (34.3
%) genes. The see and pvl genes were not detected in any of
the S. aureus isolates obtained from blood. MRSA and MSSA
isolates from blood showed different prevalences of entero-
toxin genes. Whereas the majority of MRSA isolates from
blood contained sec (66.7%), seg (86.1%), sei (83.3%), and
tst (72.2%) genes, less than 30% of the MSSA isolates from
blood were positive for those genes. With regard solely to
the sea gene, the MSSA isolates showed significantly higher
prevalence than was observed in the MRSA isolates (P=0.041). 
Among the 95 S. aureus isolates obtained from nasal spec-
imens, 78 isolates (82.1%) were positive for at least one entero-
toxin gene. The most prevalent enterotoxin gene in S. aureus
isolates from nasal specimens was sei (70.5%), followed by
seg (61.1%), tst (52.6%), and sea (47.4%) genes. As compared
with the S. aureus isolated from blood, S. aureus isolates from
















sea 5 (13.9) 10 (29.4) 4 (22.2) 31 (40.3) 15 (21.4) 45 (47.4) 0.041
seb 2 (5.6) 2 (5.9) --4 (5.8) - 0.031
sec 24 (66.7) - 2 (11.1) - 24 (34.3) 2 (2.1) <0.000
sed 1 (2.8) 1 (3.0) --2 (2.9) - 0.178
see -- -- - - -
seg 31 (86.1) 10 (29.4) 12 (66.7) 46 (59.7) 41 (58.6) 58 (61.1) 0.789
seh 2 (5.6) 3 (8.8) 5 (27.8) 24 (31.2) 5 (7.2) 29 (30.5) 0.001
sei 30 (83.3) 9 (26.5) 13 (72.2) 54 (70.1) 39 (55.7) 67 (70.5) 0.056
sek 5 (13.9) 4 (11.8) - 5 (6.5) 9 (12.9) 5 (5.3) 0.087
tst 26 (72.2) 5 (14.7) 9 (50.0) 41 (53.3) 31 (44.3) 50 (52.6) 0.259
pvl -- -- - - -
Table 3. Prevalence of enterotoxin genes and pvl gene
Gene combination
No. of S. aureus isolates
Blood Total Nasal specimens
sec, seg, sei, tst 21 1 22
sea, seg, sei, tst 41 21 6
seg, sei 61 01 6
sea, seg, seh, sei, tst 11 11 2
seg, sei, tst 99




seg, seh, sei, tst 134
sea, seh, sek 213
seg, seh, sei 123
sea, seg, seh, sei, sek, tst 22
sea, sei 22
tst 22
sea, sed, seg, sei, tst 11
sea, seg, seh, sei 11
sea, seg, sei, sek, tst 11
seb, sec, seg, sei, tst 21
seb, sed, seg, sei 11
seb, sec, seg, sei, sek, tst 1
seb 11
sec, seg, tst 11
sec, tst 11
seg 11
seg, seh, sei, sek 11
seh, sei, tst 11
seh, tst 11
sei 11
None 20 17 37
Total 70 95 165
Table 4. Combination of enterotoxin genes in S. aureus from
blood and nasal specimens
MRSA, methicillin-resistant S. aureus; MSSA, methicillin-susceptible S. aureus.nasal specimens showed significantly higher prevalence of
sea and seh genes (P=0.041 and 0.001, respectively) and sig-
nificantly lower prevalence of seb and sec genes (P=0.031 and
<0.001, respectively) (Table 3). No seb, sed, see, and pvl genes
were detected in the S. aureus isolates from nasal specimens.
By way of contrast with the S. aureus isolates from blood, no
significant differences in prevalence were detected between
MRSA and MSSA isolates. 
Among S. aureus isolates from blood, the most prevalent
combination of enterotoxin genes was a combination of sec-
seg-sei-tst (21 isolates, 30.0%), followed by combinations of
seg-sei (6 isolates, 8.6%) and sea-sek (6 isolates, 8.6%) (Table
4). However, only one isolate from the nasal specimens showed
combination of sec-seg-sei-tst. The most prevalent combina-
tions of enterotoxin genes in S. aureus isolates from nasal spec-
imens were sea-seg-sei-tst (12 isolates, 12.6%), sea-seg-seh-sei-
tst (11 isolates, 11.6%), and seg-sei (10 isolates, 10.5%) (Table
4). 
Distribution of enterotoxin genes by genotypes
In this analysis, we included all S. aureus isolates obtained
from blood and nasal specimens (Table 5). Among the 29 iso-
lates of spa-CC002, most contained sec (89.7%), seg (93.1%),
sei (89.7%), and tst (89.7%) genes. Overall, 22 isolates of the
spa-CC002 (75.9%) showed a combination of sec, seg, sei, and
tst genes. It is worthy of note that the sec gene is found only
in S. aureus isolates of spa-CC002. Only one isolate (3.5%) of
spa-CC002 harbored no enterotoxin genes. 
Among the 48 isolates of spa-CC037, sea, seg, sei, and tst
genes were found in more than 50%. The distribution of en-
terotoxin genes in S. aureus isolates differed with respect to
their sources. Whereas the sea and sek genes were detected
in 92.9% and 42.9% of the isolates from blood, they were
positive for 61.8% and 3.0% of the isolates from nasal spec-
imens, respectively. However, S. aureus isolates from blood
contained seh and sei genes at rates of 7.2% and 50.0%, but
isolates from nasal specimens contained those genes at rates
of 26.5% and 91.2%, respectively. Four isolates (8.3%) were
found to be negative for all enterotoxin genes. Isolates of spa-
CC008 harbored few enterotoxin genes. 
DISCUSSION
According to the results of genotypic analysis using spa typ-
ing and MLST, MRSA strains from blood have different genet-
ic backgrounds from MSSA strains. Whereas the majority of
MRSA strains were limited to three spa groups, the MSSA
strains were dispersed into a variety of groups. In this study,
ST5-MRSA-II corresponding to spa-CC002 was the most
prevalent MRSA clone that caused bacteremia, a result which
was consistent with the result of previous study (23), in which
clinical isolates from all types of specimens were included.
However, only one MSSA isolate belonged to ST5. spa-CC002
or ST5 was not a principal clone in the S. aureus isolates ob-
tained from nasal specimens (4 out of 95 isolates, 4.2%) (14).
spa-CC084, which corresponds to CC72 in MLST, was the
second most prevalent genotype in MRSA strains from blood,
but was not detected in MSSA strains. This clone was the most
prevalent in the MRSA isolates from nasal specimens (9 out
of 18 isolates, 50.0%) (14). spa-CC084 was the most preva-
lent clone in the MSSA strains obtained from blood, and was
also frequently detected in the MRSA strains. In addition,
it was also the most prevalent in S. aureus isolates obtained
from nasal specimens (34 out of 95 isolates, 35.8%) (14). How-
ever, it was not detected in MRSA isolates obtained from nasal
specimens, that is, all S. aureus isolates of spa-CC037 obtained
from nasal specimens were found to be methicillin-susceptible.
Notably, spa-CC037 of MSSA may differ from that of MR-
SA. The MRSA isolates of spa-CC037 corresponded to ST239
or its single locus variants, which were previously shown (23).
However, only some strains of MSSA of spa-CC037 (spa type,
WGKAOMQ) might belong to ST239, and the other six
MSSA strains of spa-CC037 belonged to ST30 or its single
locus variants. Although clones of ST239 and ST30 share the
same allele at only one locus of arcC, ST239 is believed to
emerge via the incorporation of a large portion of chromo-
some of ST30 into that of ST8 (24). In this study, spa types
of ST8 (YHGFMBQBLO and YGFCBQBLO; spa-CC008)
were quite different from those of ST239 (WGKAOMQ and
WGKAKAOMQ; spa-CC037). The emergence and molec-
ular evolution of ST8, ST30, and ST239 should be investi-
gated further, because they constitute the prevalent epidem-
ic clones of MRSA worldwide. 
Enterotoxin Genes in Staphylococcus aureus 589
No. (%) of isolates 
spa CC (No.)
sea seb sec sed seg seh sei sek tst
spa-CC002 (29) 1 (3.5) 3 (10.3) 26 (89.7) 1 (3.5) 27 (93.1) - 26 (89.7) - 26 (89.7)
spa-CC008 (12) 2 (16.7) 1 (8.3) -- 1 (8.3) 2 (16.7) 1 (8.3) 1 (8.3) -
spa-CC037 (48) 34 (70.8) -- 1 (2.1) 36 (75.0) 10 (20.8) 38 (79.2) 7 (14.6) 24 (50.0)
spa-CC084 (49) 9 (18.4) --- 26 (53.1) 14 (28.6) 29 (59.2) 5 (10.2) 18 (36.7)
spa-CC1039 (4) 1 (25.0) --- 1 (25.0) 3 (75.0) 1 (25.0) - 2 (50.0)
t375 (5) 2 (40.0) --- 3 (60.0) 1 (20.0) 3 (60.0) - 3 (60.0)
t1151 (7) ---- 1 (14.3) 1 (14.3) 1 (14.3) - 2 (28.6)
Table 5. Distribution of enterotoxin genes by spa clonal complexes (spa-CC)The prevalence of enterotoxin genes in S. aureus isolates
from blood differed significantly from those obtained from
nasal specimens with regard to the sea, seb, sec, and seh genes;
whereas the seb and sec genes were present at higher levels in
the blood isolates, the sea and seh genes were more frequently
detected in the isolates from nasal specimens. Cha et al. (13)
previously reported the prevalence of virulence genes in S.
aureus isolates associated with staphylococcal food poisoning
in Korea. In their study, the sea gene was detected in the ma-
jority of isolates (91.9%). In their study, the isolates with the
sea gene were distributed in diverse clones, but were primari-
ly detected in ST1, ST30, and ST59. That is, S. aureus strains
that cause food poisoning are different clones from those that
cause bacteremia or nasal colonization, according to MLST.
The seh gene was also detected frequently in food poisoning-
associated S. aureus isolates (198/332 isolates, 59.6%) (13).
The seh gene was only infrequently detected in clinical iso-
lates of S. aureus from Jordan (25). As the nasal carriage of S.
aureus strains can be a cause of the contamination of manually
handled food and transmission among humans, the relatively
high presence of sea and seh genes in S. aureus isolates from nasal
specimens constitutes a continuing matter of concern (26). 
The tst gene encodes for TSST-1, which is associated with
staphylococcal toxic shock syndrome (TSS) and is considered
to be the cause of nearly all cases of menstrual TSS, and of at
least 50% of nonmenstrual cases (11). As a whole, there was
not significant difference of prevalence of tst gene between
blood and nasal isolates. It is particularly noteworthy that
the tst gene was highly prevalent in MRSA isolates from blood
(72.2%). However, it was not significant as compared with
MRSA isolates from nasal carriage (50.0%). Contrast to MR-
SA isolates, MSSA isolates from nasal carriage showed high-
er prevalence of tst gene than those from blood (53.3% vs.
14.7%). As has been reported by Chini et al. (27), the tst gene
is considered to coexist with the enterotoxin gene cluster (egc),
which includes seg and sei. However, among 97 isolates har-
boring both the seg and sei genes, 70 isolates (72.2%) were
positive for the tst gene in our study.
The sec gene was frequently detected in S. aureus isolates
from blood rather than from nasal specimens, which is a sig-
nificant finding. The sec gene has been detected in only one
isolate among food poisoning-associated isolates (13). This
virulence gene was present exclusively in the MRSA isolates
of a particular clone, spa-CC002 corresponding to ST5 in this
study. A previous study in Korea reported that sec gene was
detected mostly in clinical MRSA isolates with SCCmec type
II, which may be correlated with ST5 in Korea. This clone,
the most prevalent one in Korean hospitals (6, 7, 13, 23, 28),
is characterized by the sec-seg-sei-tst gene combination. In gen-
eral, prevalent S. aureus clones tended to harbor more viru-
lence genes than minor clones. It has been reported that suc-
cessful S. aureus clones usually harbor the seg and sei genes (29).
This suggests that repertoires of virulence genes may be co-
adapted to the genetic background, and that they may con-
tribute to the biological fitness of the lineages into certain
environments (9, 29). It is currently known that only sever-
al epidemic MRSA clones (such as CC5, CC8, CC22, CC30,
and CC45) have spread worldwide (30, 31).
Despite the general relationships existing between genetic
backgrounds and repertoires of virulence genes, there is some
evidence to suggest considerable transmission of virulence
genes on a background of clonality (10). Variations in viru-
lence genes within a certain clone are suggestive of a common
horizontal transfer of such genes. For example, the sea, seb,
and sed genes existed solely in some isolates of spa-CC002.
In addition, the sec, seg, sei, and tst genes existed in the major-
ity of isolates of spa-CC002, but two (seg) or three (sec, sei, and
tst) isolates did not harbor them. 
In short, S. aureus isolates from blood have genotypes dif-
ferent from those obtained from nasal specimens. In addition,
the genetic background of MRSA isolates that cause bacte-
remia was different from those of the MSSA isolates. S. aureus
isolates from blood showed different prevalences in virulence
genes from those obtained from nasal specimens. Some preva-
lent clones have characteristic virulence gene repertoires. The
possession of virulence genes may affect the biological fitness
of S. aureus, in addition to their pathogenesis, as suggested
by van Belkum et al. (29). However, S. aureus clones causing
bacteremia may differ from those causing nasal colonizer (7,
14, 32). The clonal difference of S. aureus isolates between
two groups could be due to demographic differences and may
indicate the different way of acquisitions of virulence genes.
Thus, it should also be mentioned that this study has the limi-
tation that the population of nasal colonizer is different from
bacteremic patients. 
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